Element Solutions
ESI
$35.19
+5.30%
Element Solutions Inc. is a specialty chemicals company operating through two reportable segments — Electronics and Industrial & Specialty — supplying performance-enhancing chemical formulations, process technologies, and assembly materials used in printed circuit boards, semiconductor packaging, and other electronics hardware, alongside industrial surface treatment and finishing chemistries. The company occupies a focused, high-value niche within the broader Basic Materials sector, positioning itself as a critical enabling supplier to electronics supply chains rather than a commodity chemical producer, with roughly 5,200 employees and a market capitalization near $6.0 billion. The current investor narrative centers on a sharp acceleration in top-line growth — most recently reported quarterly revenue rose more than 40% year-over-year — driven by the Electronics segment, which generated $633.5 million of segment revenue and benefits from secular demand tied to semiconductor packaging and advanced circuit fabrication. At the same time, debate has intensified around profitability quality: recent quarterly net income and EBITDA have been volatile, with a large Q1 2026 acquisition ($864.2 million of cash used for acquisitions) reshaping the balance sheet and raising questions about integration, leverage, and whether the revenue surge can translate into durable earnings and free cash flow.…
ESI
Element Solutions
$35.19
Investment Opinion: Should I buy ESI Today?
Rating: Hold. Element Solutions presents a high-risk, high-reward proposition: the 41.5% revenue growth and 43.3% analyst upside to the $46.91 average target are compelling, but the collapse in net margin to 6.65% and 28.8% three-month underperformance warrant caution until profitability stabilizes. The strong buy consensus (1.27 recommendation mean) and forward PE of 15.5x suggest the market is underestimating the earnings recovery, but execution risk on the $864.2 million acquisition is significant.
Supporting evidence for a Hold includes: (1) forward PE of 15.5x is attractive relative to trailing PE of 31.6x, implying expected EPS growth to $2.43; (2) revenue growth of 41.5% YoY is exceptional and driven by secular Electronics demand; (3) gross margin remains healthy at 38.4% (though down from 42.2% a year ago); (4) free cash flow of $120.9 million provides some cushion; and (5) analyst targets range from $42 to $55, with the average implying 43% upside. However, the current ratio of 3.68 and debt-to-equity of 0.61 are manageable but not fortress-like.
The biggest risks that could invalidate the thesis are: (1) failure to integrate the acquisition and realize synergies, leading to sustained margin pressure; (2) a semiconductor demand downturn that reduces Electronics segment revenue; and (3) further multiple compression if earnings fail to meet the $2.43 EPS estimate. The rating would upgrade to Buy if operating margin recovers above 13% and free cash flow exceeds $200 million, or downgrade to Sell if revenue growth decelerates below 20% or net margin falls below 5%. At 15.5x forward earnings, the stock is undervalued relative to its growth potential, but the market is pricing in significant execution risk.
Sign up to view all
ESI 12-Month Price Forecast
Element Solutions is at an inflection point: the 41.5% revenue growth and 43% analyst upside are compelling, but the market is clearly concerned about earnings quality, as evidenced by the 28.8% three-month decline. The forward PE of 15.5x suggests that if the company can deliver on its $2.43 EPS estimate, the stock is significantly undervalued. However, the collapse in net margin to 6.65% and the $864.2 million acquisition integration risk create substantial uncertainty. I would upgrade to bullish if Q2 2026 shows operating margin recovering above 13% and free cash flow accelerating, or downgrade to bearish if revenue growth decelerates below 20% or margins fail to improve. The risk/reward is balanced at current levels, favoring a neutral stance until clearer evidence of margin recovery emerges.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Element Solutions's 12-month outlook, with a consensus price target around $46.73 and implied upside of +32.8% versus the current price.
Average Target
$46.73
0 analysts
Implied Upside
+32.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $55
Analyst target range
Bulls vs Bears: ESI Investment Factors
The bear case currently has stronger near-term evidence: ESI's 41.5% revenue growth is impressive, but net margin collapsed to 6.65% and EPS fell to $0.23 from $0.40 a year ago, while the stock has underperformed the S&P 500 by 30.8% over three months. The bull case rests on forward estimates — a 15.5x forward PE and 43% analyst upside — which require successful integration of the $864.2 million acquisition and a return to historical margin levels. The single most important tension is whether the revenue surge from the Electronics segment can be converted into durable earnings and free cash flow, or whether cost inflation and acquisition-related charges will keep profitability depressed. If margins recover toward the 13-15% operating margin seen in prior quarters, the stock is deeply undervalued; if they remain near current levels, the forward estimates are at risk.
Bullish
- Revenue accelerating at 41.5% YoY: Q1 2026 revenue reached $840.0 million, up 41.5% year-over-year from $593.7 million in Q1 2025. This is the strongest top-line growth in the dataset and is driven by the Electronics segment, which generated $633.5 million of segment revenue. The acceleration suggests ESI is capturing secular demand tied to semiconductor packaging and advanced circuit fabrication.
- Analyst consensus strong buy with 43% upside: All 11 covering analysts rate ESI a strong buy (recommendation mean 1.27), with an average target price of $46.91 versus the current $32.73 — implying 43.3% upside. The low target of $42.00 still represents 28.3% upside, indicating that even the most cautious analyst sees meaningful value at current levels.
- Forward PE of 15.5x is undemanding: ESI trades at a forward PE of 15.5x based on estimated EPS of $2.43, well below the trailing PE of 31.6x. This steep drop reflects expected earnings normalization as acquisition costs annualize and integration synergies materialize. A 15.5x forward multiple for a company growing revenue at 41.5% represents a compelling growth-at-a-reasonable-price setup.
- Strong balance sheet with 3.68 current ratio: The current ratio of 3.68 indicates robust short-term liquidity, and debt-to-equity of 0.61 is manageable for a specialty chemicals company. Despite the $864.2 million Q1 2026 acquisition, ESI maintains a healthy capital structure with $120.9 million in trailing free cash flow to service obligations.
Bearish
- Profitability quality deteriorating sharply: Q1 2026 net income of $55.9 million represents a net margin of just 6.65%, down from 16.5% in Q1 2025 despite 41.5% revenue growth. EBITDA fell to $146.7 million from $167.3 million a year earlier, and EPS declined to $0.23 from $0.40. The revenue surge is not translating into earnings, raising serious questions about cost inflation and acquisition-related dilution.
- Acquisition integration risk and leverage: The $864.2 million cash acquisition in Q1 2026 significantly reshaped the balance sheet, contributing to a negative income before tax of -$50.4 million in Q4 2025 due to a $120.1 million other expense. Integration missteps, goodwill impairment, or failure to realize synergies could pressure earnings and cash flow for multiple quarters.
- Severe relative underperformance over 3 months: ESI has declined 28.8% over the past three months while the S&P 500 gained 2.0%, resulting in a relative strength of -30.8%. This dramatic underperformance suggests the market is pricing in concerns about earnings quality, integration risk, or sector rotation out of specialty chemicals, and momentum remains negative.
- High EV/EBITDA and PCF ratios: EV/EBITDA of 22.0x and price-to-cash-flow of 20.9x are elevated for a specialty chemicals company, especially one with volatile earnings. These multiples leave little room for error; any earnings miss or guidance cut could trigger significant multiple compression. The PEG ratio of -1.45 further signals that earnings growth is not yet supporting the valuation.
ESI Technical Analysis
Beta
1.26
1.26x market volatility
Max Drawdown
-35.2%
Largest decline past year
52-Week Range
$23-$49
Price range past year
Annual Return
+33.2%
Cumulative gain past year
| Period | ESI Return | S&P 500 |
|---|---|---|
| 1m | -0.3% | +1.0% |
| 3m | -23.7% | +5.5% |
| 6m | +3.6% | +19.9% |
| 1y | +33.2% | +16.0% |
| ytd | +35.7% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ESI Fundamental Analysis
Quarterly Revenue
$840000000.0B
2026-03
Revenue YoY Growth
+41.5%
YoY Comparison
Gross Margin
38.4%
Latest Quarter
Free Cash Flow
$120900000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ESI Overvalued?
PE
31.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 14x~40x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
22.0x
Enterprise Value Multiple
Investment Risk Disclosure
Element Solutions faces significant financial and operational risks stemming from its recent acquisition and deteriorating profitability. The company used $864.2 million in cash for acquisitions in Q1 2026, which, combined with a debt-to-equity ratio of 0.61, has increased leverage and integration complexity. Despite 41.5% revenue growth, net income fell to $55.9 million (6.65% net margin) from $98.0 million (16.5% net margin) a year earlier, and EBITDA declined to $146.7 million from $167.3 million. Free cash flow of $120.9 million trailing twelve months is modest relative to the $6.0 billion market cap and may be insufficient to rapidly deleverage if integration costs persist. Additionally, revenue concentration in the Electronics segment ($633.5 million) exposes the company to cyclical semiconductor and electronics demand swings.
Market and competitive risks are elevated given ESI's premium valuation on some metrics and recent underperformance. The stock trades at 22.0x EV/EBITDA and 20.9x price-to-cash-flow, which are rich for a specialty chemicals company with volatile earnings. With a beta of 1.26, ESI is more volatile than the broader market, and the 28.8% three-month decline (versus S&P 500 +2.0%) suggests negative momentum and potential sector rotation away from basic materials. Competitive pressures in specialty chemicals are intense, with larger players potentially eroding ESI's niche advantages. Furthermore, the absence of recent news in the dataset means the market may be reacting to undisclosed competitive or macro developments, adding uncertainty.
The worst-case scenario involves a failed integration of the $864.2 million acquisition, continued margin compression, and a semiconductor demand downturn. In this scenario, ESI could retest its 52-week low of $22.86, representing a 30.2% decline from the current price of $32.73. If analyst bear-case targets are revised downward toward the low end of $42.00 (which currently implies upside), a more severe scenario could see the stock fall to the $22-25 range, implying a loss of 24-30%. The maximum drawdown over the past 180 days was -35.24%, indicating that such a decline is historically plausible within a six-month period. Investors could lose approximately 30% from current levels in this adverse scenario.
FAQ
The key risks ranked by severity are: (1) Integration risk from the $864.2 million acquisition, which could lead to goodwill impairments or sustained margin pressure; (2) Profitability risk, as net margin has fallen to 6.65% and EBITDA declined to $146.7 million from $167.3 million YoY; (3) Market risk, with a beta of 1.26 and 28.8% three-month underperformance indicating negative momentum; and (4) Cyclical risk, as the Electronics segment ($633.5 million revenue) is tied to semiconductor demand, which can be volatile. Additionally, the debt-to-equity of 0.61 and current ratio of 3.68 are manageable but could deteriorate if cash flow weakens.
The 12-month forecast has three scenarios: Bull case (30% probability) targets $50-55, assuming successful integration and margin recovery to 15%; Base case (50% probability) targets $42-48, assuming gradual margin recovery to 12-13% and EPS of $2.43; Bear case (20% probability) targets $22.86-30, assuming a semiconductor downturn and failed integration. The base case is most likely, supported by the analyst average target of $46.91 and forward EPS estimates. The key assumption is that operating margin recovers to at least 12% by late 2026, allowing the stock to re-rate toward 18x forward earnings.
ESI appears undervalued on forward earnings but overvalued on trailing metrics. The forward PE of 15.5x is attractive for a company growing revenue at 41.5%, and the PEG ratio of -1.45 (negative due to depressed trailing earnings) suggests the market is not pricing in future growth. However, the trailing PE of 31.6x and EV/EBITDA of 22.0x are elevated, reflecting the current earnings trough. Relative to the specialty chemicals sector, ESI's price-to-sales of 2.37x is moderate, but its price-to-cash-flow of 20.9x is high. The market is pricing in a successful integration and margin recovery; if that fails, the stock could be overvalued at current levels.
From a risk/reward perspective, ESI is a speculative buy for investors who believe in the margin recovery story. The stock trades at $32.73, with a forward PE of 15.5x and analyst average target of $46.91, implying 43.3% upside. However, the net margin has collapsed to 6.65% from 16.5% a year ago, and the stock has underperformed the S&P 500 by 30.8% over three months. The biggest downside risk is a retest of the 52-week low of $22.86, representing a 30% loss. It is a good buy only for investors with a high risk tolerance and a 12-18 month horizon who are confident that the acquisition integration will succeed and margins will recover.
ESI is more suitable for medium-to-long-term investment (12-24 months) rather than short-term trading. The stock's beta of 1.26 and recent 28.8% three-month decline indicate high volatility, making it risky for short-term traders. The dividend yield of 1.29% and payout ratio of 40.8% provide modest income but are not the primary attraction. The investment thesis hinges on a multi-quarter margin recovery and acquisition integration, which requires patience. A minimum holding period of 12 months is suggested to allow for earnings normalization and potential re-rating toward analyst targets. Short-term traders might exploit volatility around earnings, but the risk/reward favors long-term positioning.